ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KALAVATHI KOLAPPA MD

Psychiatry

3,046

$356K

214
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $137

THOMAS GRESALFI

Psychiatry

2,992

$299K

168
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $137

VISWANATHAN SWAMINATHAN M.D.,DFAPA

Psychiatry

2,985

$352K

205
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$118
Average prescription price

Avg: $137

TRAVIS ANDERSON MD

Psychiatry

2,969

$537K

204
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 26%

$181
Average prescription price

Avg: $137

BYRON STROTHER M.D., J.D.

Psychiatry

2,969

$137K

197
14 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $137

DEVENDRA SHAH M.D.

Psychiatry

2,964

$472K

183
48 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 26%

$159
Average prescription price

Avg: $137

ALOK UPPAL M.D.

Psychiatry

2,963

$283K

172
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$95
Average prescription price

Avg: $137

JOHN HUMPHREY MD

Psychiatry

2,953

$318K

218
144 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 26%

$108
Average prescription price

Avg: $137

ROBERT FLEURY M.D.

Psychiatry

2,953

$291K

287
47 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $137

KAREN BILLMIRE M.D.

Psychiatry

2,942

$551K

114
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$187
Average prescription price

Avg: $137

PATRICIA WESSON M.D.

Psychiatry

2,933

$298K

179
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$102
Average prescription price

Avg: $137

KYLE LONG MD

Psychiatry

2,933

$414K

152
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$141
Average prescription price

Avg: $137

CAREY COTTLE MD

Psychiatry

2,927

$314K

203
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$107
Average prescription price

Avg: $137

FLOYD WISEMAN M.D.

Psychiatry

2,919

$403K

124
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$138
Average prescription price

Avg: $137

WEI ZHANG M.D.

Psychiatry

2,891

$392K

254
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $137

ISABELLE EUSTICE MD

Psychiatry

2,847

$282K

241
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$99
Average prescription price

Avg: $137

JOSEPH GODFREY M.D.

Psychiatry

2,820

$383K

143
44 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $137

JOHN BARKENBUS MD

Psychiatry

2,811

$460K

221
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$164
Average prescription price

Avg: $137

MICHAEL GOLDING M.D.

Psychiatry

2,796

$427K

136
23 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$153
Average prescription price

Avg: $137

KENNETH LEETZ MD

Psychiatry

2,767

$355K

192
92 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $137

LYNN WESSON MD

Psychiatry

2,764

$346K

179
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$125
Average prescription price

Avg: $137

SHABBIR CHOWDHURY M.D.

Psychiatry

2,730

$449K

212
47 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 26%

$164
Average prescription price

Avg: $137

JAY YEOMANS M.D.

Psychiatry

2,729

$362K

196
49 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $137

KARUNA UPPAL M.D.

Psychiatry

2,710

$223K

139
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$82
Average prescription price

Avg: $137

BERNARD EATON MD

Psychiatry

2,683

$387K

175
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$144
Average prescription price

Avg: $137

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank